APOE and atherosclerosis: In the apolipoprotein E (Apoe)-deficient mouse atherosclerosis model, antibiotic treatment resulted in increased atherosclerosis, connected to a loss of intestinal microbiome diversity and alterations in microbial metabolic functional capacity with a major impact on the host serum metabolome (Kappel et al. 2020).